| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate |
2006-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2008-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1905434-A1 |
| titleOfInvention |
Organic compounds comprising an S1P receptor agonist and their therapeutic use |
| abstract |
The present invention provides a solid pharmaceutical composition suitable for oral administration, comprising an S1P receptor agonist in the absence of a sugar alcohol. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11759436-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012080641-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10543179-B2 |
| priorityDate |
2006-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |